GLP-1 therapies (glucagon-like peptide-1 receptor agonists) are a class of medications that mimic the natural GLP-1 hormone, which helps regulate blood sugar and appetite. They were originally used for managing type 2 diabetes, but are now also approved for treating obesity and weight loss. Some GLP-1 drugs lower the risk of heart attack, stroke, and heart failure, and reduce the incidence of ...
Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and obesity. GLP-1 receptor ago...
Yale Medicine experts explain how new GLP-1 weight-loss pills work, how they compare to injections, and what to consider before trying them.
Introduction: The Obesity Drug Revolution Is Entering a New Phase Obesity treatment is undergoing a major transformation. Over the past decade, therapies targeting incretin hormones have reshaped clinical practice, but the next five years (20262030) are expected to redefine obesity medicine entirely. The field is evolving from single-hormone appetite suppression to multi-hormonal metabolic ...
GLP-1 medications have been life changing for so many people with obesity, says Jody Dushay, MD, an assistant professor of medicine at Harvard Medical School and an endocrinologist at the Beth Israel Deaconess Medical Center in Boston. In the field of medical weight management, its been amazing.
This Special Communication summarizes the WHO guideline on the management of obesity with GLP-1 therapies in adults and calls on nations to ensure equitable access to obesity prevention and management interventions.
One version of the medicine is now available in pill form, and therapists who treat eating disorders are worried it will be abused. (Edwin J. Torres for NPR). This is the kind of paradox that Jason Krynicki, the New Jersey man, understands about GLP-1s.
